Autoimmune disease is frequent in patients with myelodysplastic syndromes, but studies have been inconclusive about how the preexistence of autoimmunity affects survival in these patients. A new study by UVM Cancer Center member Diego Adrianzen Herrera, M.D. uses an epidemiologic analysis to clarify that issue.

Most children are exposed to adversity by the time they reach adulthood, but a portion of children stay free of mental illness despite trying circumstances. A recent study led by Professor of Psychiatry William Copeland, Ph.D., and supported by UVM researchers, challenges the notion that childhood resilience is common and explores possible solutions to this crisis via public health initiatives.

A new collaboration between Vermont Medicaid and UVM Medical Center’s Comprehensive Pain Program allows Medicaid members with chronic pain to participate in complementary therapies including health coaching, massage, yoga, nutrition, acupuncture, and meditation. This pilot is an important step toward eliminating disparities in access to effective, integrative care for pain.

UVM’s Novel DNA Extraction Technology Goes to the International Space Station: Tighe, Tracy, and Dragon to Support ISS Astronauts’ Experiments

To reduce barriers to skin cancer screening, the University of Vermont Cancer Center works with the UVM Cancer Center’s community advisory board member, Chief Donald Stevens, tribal leader for the Nulhegan Band of the Coosuk Abenaki Nation to bring skin checks out to communities in Vermont.

UVM and icddr,b the first to study a promising dengue vaccine in dengue-endemic Bangladesh

Katharine Cheung, M.D., Ph.D., assistant professor of medicine, assumed the role of Interim Director of the Center on Aging, effective September 1. A geriatric and palliative nephrologist, Cheung served on the center’s advisory board from 2017-2023. As interim director, Cheung's top priorities include relaunching pilot grants for faculty who are interested in pursuing research focused on gerontology or geriatric issues.